Chongqing Zhifei Biological Products Co., Ltd.
300122
Kedudukan dalam Saham
#3781
Chongqing Zhifei Biological Products Co., Ltd. is a Chinese firm primarily... Chongqing Zhifei Biological Products Co., Ltd. is a Chinese firm primarily engaged in the innovation, manufacturing, and commercialization of vaccines and other biological pharmaceuticals within the country. The company's establishment dates back to 2009, and its main operational base is located in Chongqing, China.
Harga Saham
$1.91
Modal Pasaran
$4.57B
Perubahan (1 hari)
5.32%
Perubahan (1 tahun)
-32.90%
Negara
CN
Perdagangan Chongqing Zhifei Biological Products Co., Ltd. (300122)
Kategori
Healthcare
Pendapatan untuk Chongqing Zhifei Biological Products Co., Ltd. (300122)
Pendapatan pada Jun 2026 TTM: $-2.56B
Menurut laporan kewangan terkini Chongqing Zhifei Biological Products Co., Ltd., pendapatan semasa syarikat ialah $-2.56B. Pada tahun 2023, syarikat memperoleh pendapatan sebanyak $1.32B, peningkatan berbanding pendapatan pada tahun 2022 yang berjumlah $1.26B. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Chongqing Zhifei Biological Products Co., Ltd. dari 2007 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Ubah |
|---|---|---|
| 2026 (TTM) | $-2.56B | -930.41% |
| 2024 | $308.76M | -76.61% |
| 2023 | $1.32B | 4.43% |
| 2022 | $1.26B | -32.67% |
| 2021 | $1.88B | 218.18% |
| 2020 | $589.97M | 48.56% |
| 2019 | $397.14M | 61.43% |
| 2018 | $246.01M | 217.15% |
| 2017 | $77.57M | 1,407.01% |
| 2016 | $5.15M | -85.51% |
| 2015 | $35.52M | 25.56% |
| 2014 | $28.29M | 12.36% |
| 2013 | $25.18M | -37.88% |
| 2012 | $40.54M | 11.01% |
| 2011 | $36.52M | -20.43% |
| 2010 | $45.89M | 20.19% |
| 2009 | $38.18M | 17.29% |
| 2008 | $32.55M | 28.15% |
| 2007 | $25.40M | 0.00% |
Pendapatan untuk syarikat atau pesaing serupa
| Syarikat | Pendapatan | Perbezaan Pendapatan | Negara |
|---|---|---|---|
| $5.27B | -305.73% |
US
|
|
| $-3.09B | 20.40% |
US
|
|
| $-4.02B | 56.64% |
AU
|
|
| - | - |
CH
|
|
| $1.95B | -176.08% |
NL
|
